Trial
NCT01528865
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
GlaxoSmithKline; Gilead Sciences
Condition
Lymphoma
Intervention
Lamivudine
Why stopped
Funding was removed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-11